Litigation Details for HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
✉ Email this page to a colleague
HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-12-15 |
Court | District Court, D. New Jersey | Date Terminated | 2016-03-24 |
Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
Jury Demand | None | Referred To | Douglas Arpert |
Parties | ROCHE PALO ALTO LLC | ||
Patents | 9,173,942 | ||
Attorneys | ISAAC SAMUEL ASHKENAZI | ||
Firms | Patunas Law LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC.
Details for HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2015-12-14 | 1 | United States Patent No. 9,173,942 (“the ’942 patent”). This action arises under the patent laws of the… THE PATENT 12. On November 3, 2015, the ’942 patent, titled “Liquid Pharmaceutical…the expiration of the ’942 patent. 16. The ’942 patent had not issued at the time …’ other Orange Book-listed patents. 17. The ’942 patent shares the same expiration… to the expiration of the ’942 patent, Defendants infringed that patent pursuant to 35 U.S.C. § 271 ( | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |